Oxford BioMedica Share Price (OXB)
| Bid price | 2.95 | Open price | 3.10 |
|---|---|---|---|
| Ask price | 3.09 | Prev close | 3.02 |
| High price | 3.22 | Spread | 4.53% |
| Low price | 2.95 | Volume | 2,548,831 |
Register now for FREE live Oxford BioMedica share prices, Oxford BioMedica stock quotes, charts, trades and FREE Oxford BioMedica company fundamentals, market news and much much more. Why not upgrade to a premium service and get Oxford BioMedica Level 2 Data, indepth research tools and investor commentary for Oxford BioMedica (OXB) and other London Stock Exchange equities.
Oxford BioMedica Share Price Chart
Register now for FREE Oxford BioMedica share price charts
Oxford BioMedica Share Price Information
| Name | Oxford BioMedica | Epic | OXB |
|---|---|---|---|
| Activites | Researches and develops genebased medicines and therapeutic vaccines based on a broad technology platform | Reuters | OXB.L |
| ISIN | GB0006648157 | Google Finance | LON:OXB |
| Share Price (p) | 3.02 | Prev. Share Price (p) | 3.02 |
|---|---|---|---|
| Shares in Issue (m) | 945 | Market Cap (£m) | 30 |
| PE Ratio (x) | -2.59 | Div per share (p) | 0.00 |
| Div yield (%) | 0.00 | Div cover (x) | |
| EPS (p) | -1.30 | PEG |
Register now for FREE Oxford BioMedica company fundamentals
Oxford BioMedica Director Deals
| Dec.Date | Type | Director | Pos | No. of Shares |
|---|---|---|---|---|
| 08/03/2012 | BUY | Tim Watts | FD | 1,000,000 |
| 08/03/2012 | BUY | Paul Blake | NED | 100,000 |
| 10/01/2011 | PLAC | Alan Kingsman | RES | 2,000,000 |
| 10/01/2011 | PLAC | John Dawson | CEO | 200,000 |
| 10/01/2011 | PLAC | Stuart Naylor | ED | 80,000 |
Oxford BioMedica Company News
Oxford BioMedica pleased with clinical results
Oxford Biomedica are are very encouraged by the first RetinoStat clinical results indicating sustained therapeutic protein expression in the eye and await further data from its ocular programmes, partnered with Sanofi, later this year. The board is also pleased with Pfizer's continued...
FLASH: Oxford BioMedica pleased with clinical results
Story provided by StockMarketWire.com
Interim Management Statement
/* */ RNS Number : 1289D Oxford Biomedica PLC 11 May 2012 Oxford BioMedica Interim Management Statement Oxford, UK - 11 May 2012: Oxford BioMedica plc ("Oxford BioMedica" or "the Company") (LSE: OXB), the leading gene-based...
More Oxford BioMedica Company News >>
Register now for FREE Oxford BioMedica company news
Oxford BioMedica Share Price Discussions
CANCER drug co. Oxford Biomedica charts (OXB)
OK so you thought the title of the other thread was out of date BUT unfortunately there is no way to edit thread titles. So here is a new title This one has got the charts at the top again & has a link to the old one....
OXFORD BIOMEDICA TO REACH NEW HIGH`S THIS WEEK...? (OXB)
Very strong rumours of a further predator around. CAT,WYEYH,JOHNSON&JOHNSON,MERCK to name a few.............could be an exciting week ...!
OXFORD BIOMEDICA TO REACH NEW HIGH`S THIS WEEK...? (OXB)
Very strong rumours of a further predator.........CAT,JOHNSON&JOHNSON,WYETH,MERCK to name a few. Could be an interesting week..!
Register now for FREE Oxford BioMedica share price discussions